Also trades as: PAR.AX (ASX) · $vol 0M
PBIGF OTC
Paradigm Biopharmaceuticals Limited
1W: -86.8%
1M: -98.9%
3M: -99.1%
YTD: -99.4%
1Y: -99.2%
3Y: -99.8%
5Y: -99.9%
$0.00
-0.00 (-17.65%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+17.4% YoY
$-75M
Net Income
+32.1% YoY
$-16M
Free Cash Flow
+83.4% YoY
-56.7%
Gross Margin
-71424.6%
Op. Margin
-60158.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-550.4%
ROA-259.2%
ROIC1492.1%
Valuation
P/E-1.6
P/B24.3
EV/EBITDA0.0
Leverage
Debt/Equity2.16
Current Ratio1.10
Interest Cov.-35.1x
Quality Scores
Piotroski F3/9
Altman Z—
Beneish M-5.84